Afinitor Approved for Advanced Breast Cancer

FRIDAY, July 20 (HealthDay News) — Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food and Drug Administration said Friday.